![](/img/cover-not-exists.png)
Frequency of zoledronic acid to prevent further bone loss in osteoporotic patients undergoing androgen deprivation therapy for prostate cancer
Vivek K. Wadhwa, Robin Weston, Nigel J. ParrVolume:
105
Year:
2010
Language:
english
Pages:
7
DOI:
10.1111/j.1464-410x.2009.08956.x
File:
PDF, 345 KB
english, 2010